January 23, 2022

Volume XII, Number 23

Advertisement

Robert P. Charrow

Robert P. Charrow focuses his practice on research, biotechnology and health care issues. He represents health care providers, scientists, pharmaceutical companies, universities, research institutes and other entities with respect to legislative, regulatory and litigation matters arising under the Federal Food, Drug, and Cosmetic Act; research issues under the Public Health Service Act; licensing issues under the Federal Technology Transfer Act, the Bayh-Dole Act and related legislation; and reimbursement and regulatory issues under Medicare and Medicaid, the False Claims Act and other federal laws.

Robert represents corporations, political action committees and candidate committees with respect to issues arising under the Federal Election Campaign Act of 1971, as amended, and ancillary legislation. He also participates regularly in preparing Supreme Court briefs and certiorari petitions. Prior to joining the firm, Robert served as Deputy General Counsel and Principal Deputy General Counsel for the U.S. Department of Health and Human Services. Robert also supervised the Chief Counsel for the various agencies within the department, including the Food and Drug Administration, the Health Care Financing Administration, and the Office of Inspector General and the Public Health Service. He actively participated in formulating department policy with respect to Medicare reimbursement, drug and device approvals, tort liability, and technology transfer.

Advertisement

Articles in the National Law Review database by Robert P. Charrow

Advertisement
Advertisement
Advertisement
Advertisement